Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 84 Prostatic Neoplasms 73 Leukemia, Myeloid, Acute 72 Carcinoma, Non-Small-Cell Lung 61 Neoplasm Metastasis 60 Breast Neoplasms 56 Multiple Myeloma 47 Colorectal Neoplasms 46 Pancreatic Neoplasms 42 Carcinoma, Renal Cell 36 Myelodysplastic Syndromes 35 Melanoma 34 Ovarian Neoplasms 33 Leukemia, Lymphocytic, Chronic, B-Cell 30 Triple Negative Breast Neoplasms 28 Glioblastoma 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Lymphoma, Large B-Cell, Diffuse 26 Urinary Bladder Neoplasms 25 Lymphoma 23 Squamous Cell Carcinoma of Head and Neck 22 Burkitt Lymphoma 22 Fallopian Tube Neoplasms 21 Glioma 20 Carcinoma, Hepatocellular 20 Brain Neoplasms 18 Mouth Neoplasms 17 Lymphoma, Non-Hodgkin 17 Leukemia, Biphenotypic, Acute 17 Endometrial Neoplasms 17

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Laparoscopy 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Specimen Handling × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡